Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers.
Our vision is to be a trusted leader in changing the practice of medicine. Novartis believes one aspect of building trust with society and research participants is through making our ongoing trials and their trial results public, regardless of the outcome of the trial.
Clinical trial results
Novartis has long been dedicated to informing the public about interventional trial results. Novartis launched the results website in 2005 becoming one of the first companies to provide this information to the public.
Trial summaries for patients
Trial summaries for patients are written in easier to understand language than the corresponding technical result summaries. Patients summaries are provided in English and local languages.
Clinical trial data sharing
Novartis is committed to sharing with qualified external researchers, access to anonymized patient level data and clinical study reports from eligible studies.
NARD (Novartis Anonymized Redacted Dossiers)
NARD is a publicly accessible website for Novartis to share dossiers submitted to Health Authorities for product approval in an anonymized/redacted format.